Editor's Note The US Food and Drug Administration (FDA) approved Lumisight (pegulicianine), a fluorescent imaging drug used to detect cancerous tissue during lumpectomy, on April 17. Administered intravenously prior to surgery, Lumisight is designed for use with the Lumicell Direct Visualization System (DVS) or another imaging device that is FDA-approved…

Read More

Editor's Note A team of Johns Hopkins researchers has designed a robot capable of performing the most complex, delicate procedures—including head and neck tumor resection—with accuracy greater than many human surgeons. As reported by the institution on March 18, ASTR: the Autonomous System for Tumor Resection is an autonomous, dual-arm,…

Read More

Editor's Note New research supports fertility preservation with cone biopsy as a viable, less radical option for to surgery in patients with early, low-risk cervical cancer, according to a report published March 18 in MedPage Today. Presented at the Society of Gynecologic Oncology annual meeting, the findings from the Gynecologic…

Read More

Editor's Note Using early postoperative endoscopy to detect anastomotic leakage after minimally invasive esophagectomy does not increase postoperative adverse events, according to a study published February 10 in the journal Surgery. Anastomotic leakage is one of the most severe adverse events of minimally invasive esophagectomy for esophageal cancer. Often deadly,…

Read More

Editor's Note Steven Rosenberg, MD, PhD, chief of the Surgery Branch at the Center for Cancer Research at the National Cancer Institute, part of the National Institutes of Health (NIH), and a pioneer in the development of immunotherapy to fight cancer, was awarded the National Medal of Technology and Innovation.…

Read More

Editor's Note Virtual reality (VR) appears to ease the pain and distress felt by patients with cancer, according to a new study published in BMJ Supportive & Palliative Care. Researchers looked at 31 relevant studies published between 1993 and 2023 in which VR technology was used to help patients, including…

Read More

Editor's Note The American Cancer Society, on May 2, announced new research that discovered both favorable and unfavorable changes in major cancer risk factors, preventive behaviors and services, and screenings during the COVID-19 pandemic. On the favorable side, smoking, physical inactivity, and heavy alcohol consumption declined, and human papillomavirus vaccination…

Read More

Editor's Note New research from the American College of Surgeons and American Cancer Society describes ways the National Cancer Database (NCDB) was impacted by the COVID-19 pandemic. For the study, researchers reviewed 4,045,097 cancer cases of adults 18 years or older who were diagnosed with cancer and/or received their first-course…

Read More

Editor's Note This study led by researchers at Columbia University Irving Medical Center, New York City, finds that race, ethnicity, and area-level social determinants of health (SDOH) were associated with delayed or discontinued cancer treatments and longer delays to restart drug-based therapies after COVID-19 infections. The analysis included data on…

Read More

Editor's Note Strides have been made in cancer treatments, diagnostic tools and prevention strategies, driving down cancer death rates, according to a report published Wednesday, September 21, by the American Association for Cancer Research, NBC News September 21 reports. According to the group’s annual Cancer Progress Report, over the past…

Read More